FDA Inspection
Lin, James P MD IncLin, James P MD Inc – FDA Inspection, Feb 28, 2011
Record Details
This FDA Inspection record concerns Lin, James P MD Inc, with an inspection on February 28, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Lin, James P MD Inc
- Inspection Date
- February 28, 2011
- Product Type
- Biologics
View Company Profile
ID · 7405659c-9029-4993-8b8f-92a9170fe72a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 712951
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Lin, James P MD Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 12, 2025 | VAI | Los Angeles District Office | Human Cellular, Tissue, and Gene Therapies |
| October 19, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 30, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 24, 2013 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 11, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Lin, James P MD Inc
- FDA Inspection 1263504 - 2025-03-12
- FDA Inspection 1182334 - 2022-10-19
- FDA Inspection 1034922 - 2017-10-30
- FDA Inspection 859037 - 2013-12-24
- FDA Inspection 813194 - 2013-01-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.